Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid

Journal:
Journal of Hepatology
Published:
DOI:
10.1016/j.jhep.2026.05.001
Affiliations:
3
Authors:
15
Go to article
Institutions Authors Share
Shanghai Changzheng Hospital, SMMU, China
10.500000
10.500000
 0.70
Shanghai East Hospital, Tongji University, China
4.000000
 0.27
The First Affiliated Hospital of Nanchang University, China
0.500000
 0.03
Interested in Clinical Sciences?